Spatio-temporal analysis of malaria within a transmission season in Bandiagara, Mali.

PubWeight™: 0.93‹?›

🔗 View Article (PMC 3618208)

Published in Malar J on March 01, 2013

Authors

Drissa Coulibaly1, Stanislas Rebaudet, Mark Travassos, Youssouf Tolo, Matthew Laurens, Abdoulaye K Kone, Karim Traore, Ando Guindo, Issa Diarra, Amadou Niangaly, Modibo Daou, Ahmadou Dembele, Mody Sissoko, Bourema Kouriba, Nadine Dessay, Jean Gaudart, Renaud Piarroux, Mahamadou A Thera, Christopher V Plowe, Ogobara K Doumbo

Author Affiliations

1: Department of Epidemiology of Parasitic Diseases, Faculty of Medicine and Dentistry, University of Sciences, Techniques and Technologies of Bamako, Point G, BP 1805, Bamako, Mali. coulibalyd@icermali.org

Associated clinical trials:

Molecular Basis of Erythrocyte Invasion by Plasmodium Vivax Into Duffy-Negative Erythrocytes in Children in Bandiagara, Mali | NCT03304691

Articles cited by this

A space-time permutation scan statistic for disease outbreak detection. PLoS Med (2005) 8.72

Spatial targeting of interventions against malaria. Bull World Health Organ (2003) 5.51

Dead bird clusters as an early warning system for West Nile virus activity. Emerg Infect Dis (2003) 3.75

Vector density gradients and the epidemiology of urban malaria in Dakar, Senegal. Am J Trop Med Hyg (1992) 3.71

Spatial clustering of malaria and associated risk factors during an epidemic in a highland area of western Kenya. Trop Med Int Health (2004) 3.31

Periodicity and space-time clustering of severe childhood malaria on the coast of Kenya. Trans R Soc Trop Med Hyg (1993) 3.16

The epidemiology of malaria in a population surrounding Madang, Papua New Guinea. Am J Trop Med Hyg (1986) 3.04

Exploring the contributions of bed nets, cattle, insecticides and excitorepellency to malaria control: a deterministic model of mosquito host-seeking behaviour and mortality. Trans R Soc Trop Med Hyg (2007) 3.01

Clustering of malaria infections within an endemic population: risk of malaria associated with the type of housing construction. Am J Trop Med Hyg (1991) 2.78

Spatial variation of malaria incidence in young children from a geographically homogeneous area with high endemicity. J Infect Dis (2008) 2.68

The microepidemiology of malaria and its importance to malaria control. Trans R Soc Trop Med Hyg (1989) 2.57

Heritability of malaria in Africa. PLoS Med (2005) 2.49

Spatial analysis of human granulocytic ehrlichiosis near Lyme, Connecticut. Emerg Infect Dis (2002) 2.21

Space-time clustering of childhood malaria at the household level: a dynamic cohort in a Mali village. BMC Public Health (2006) 2.20

Rationalizing historical successes of malaria control in Africa in terms of mosquito resource availability management. Am J Trop Med Hyg (2004) 2.13

Plasmodium infection and its risk factors in eastern Uganda. Malar J (2010) 2.13

Using the SaTScan method to detect local malaria clusters for guiding malaria control programmes. Malar J (2009) 2.06

Community permission for medical research in developing countries. Clin Infect Dis (2005) 2.01

The trouble with eaves; house entry by vectors of malaria. Trans R Soc Trop Med Hyg (1988) 2.01

An analysis of the geographical distribution of severe malaria in children in Kilifi District, Kenya. Int J Epidemiol (1998) 1.96

Impact of preseason treatment on incidence of falciparum malaria and parasite density at a site for testing malaria vaccines in Bandiagara, Mali. Am J Trop Med Hyg (2002) 1.88

Socio-economic risk factors for malaria in a peri-urban area of The Gambia. Trans R Soc Trop Med Hyg (1995) 1.83

Incidence of severe Plasmodium falciparum malaria as a primary endpoint for vaccine efficacy trials in Bandiagara, Mali. Vaccine (2004) 1.70

Detecting spatiotemporal clusters of accidental poisoning mortality among Texas counties, U.S., 1980 - 2001. Int J Health Geogr (2004) 1.65

Using a geographical information system to plan a malaria control programme in South Africa. Bull World Health Organ (2003) 1.62

Wind direction and proximity to larval sites determines malaria risk in Kilifi District in Kenya. Nat Commun (2012) 1.36

Geographical and temporal distribution of human giardiasis in Ontario, Canada. Int J Health Geogr (2003) 1.30

Environmental, socio-demographic and behavioural determinants of malaria risk in the western Kenyan highlands: a case-control study. Trop Med Int Health (2009) 1.16

Community pyrimethamine-sulfadoxine use and prevalence of resistant Plasmodium falciparum genotypes in Mali: a model for deterring resistance. Am J Trop Med Hyg (1996) 1.14

Assessment of different sources of variation in the antibody responses to specific malaria antigens in children in Papua New Guinea. Int J Epidemiol (2000) 1.02

Spatial and temporal patterns of malaria incidence in Mozambique. Malar J (2011) 0.95

Risk factors for malaria: a microepidemiological study in a village in Sri Lanka. Trans R Soc Trop Med Hyg (1998) 0.93

[Spatial cluster detection without point source specification: the use of five methods and comparison of their results]. Rev Epidemiol Sante Publique (2007) 0.91

Living conditions and occurrence of malaria in a rural community. Indian J Malariol (1991) 0.89

Articles by these authors

Spread of artemisinin resistance in Plasmodium falciparum malaria. N Engl J Med (2014) 11.87

The genetic structure and history of Africans and African Americans. Science (2009) 10.65

The pathogenic basis of malaria. Nature (2002) 10.44

Return of chloroquine antimalarial efficacy in Malawi. N Engl J Med (2006) 7.70

Exposure to environmental microorganisms and childhood asthma. N Engl J Med (2011) 6.38

Molecular markers for failure of sulfadoxine-pyrimethamine and chlorproguanil-dapsone treatment of Plasmodium falciparum malaria. J Infect Dis (2002) 5.75

A research agenda to underpin malaria eradication. PLoS Med (2011) 5.34

Multiple populations of artemisinin-resistant Plasmodium falciparum in Cambodia. Nat Genet (2013) 5.22

Reemergence of chloroquine-sensitive Plasmodium falciparum malaria after cessation of chloroquine use in Malawi. J Infect Dis (2003) 5.21

Analysis of Plasmodium falciparum diversity in natural infections by deep sequencing. Nature (2012) 4.37

Genome-wide and fine-resolution association analysis of malaria in West Africa. Nat Genet (2009) 4.30

The threat of artemisinin-resistant malaria. N Engl J Med (2011) 4.15

Genetic loci associated with delayed clearance of Plasmodium falciparum following artemisinin treatment in Southeast Asia. Proc Natl Acad Sci U S A (2012) 4.10

Mechanisms of resistance of malaria parasites to antifolates. Pharmacol Rev (2005) 4.04

Understanding the cholera epidemic, Haiti. Emerg Infect Dis (2011) 3.57

A field trial to assess a blood-stage malaria vaccine. N Engl J Med (2011) 3.20

X-linked G6PD deficiency protects hemizygous males but not heterozygous females against severe malaria. PLoS Med (2007) 2.94

A prospective analysis of the Ab response to Plasmodium falciparum before and after a malaria season by protein microarray. Proc Natl Acad Sci U S A (2010) 2.90

Sickle cell trait is associated with a delayed onset of malaria: implications for time-to-event analysis in clinical studies of malaria. J Infect Dis (2008) 2.77

Negligible risk for epidemics after geophysical disasters. Emerg Infect Dis (2006) 2.62

Season, fever prevalence and pyrogenic threshold for malaria disease definition in an endemic area of Mali. Trop Med Int Health (2005) 2.57

Origin and dissemination of Plasmodium falciparum drug-resistance mutations in South America. J Infect Dis (2002) 2.54

Therapeutic blockade of PD-L1 and LAG-3 rapidly clears established blood-stage Plasmodium infection. Nat Immunol (2011) 2.54

Intermittent preventive therapy for malaria during pregnancy using 2 vs 3 or more doses of sulfadoxine-pyrimethamine and risk of low birth weight in Africa: systematic review and meta-analysis. JAMA (2013) 2.51

Impact of intermittent preventive treatment with sulphadoxine-pyrimethamine targeting the transmission season on the incidence of clinical malaria in children in Mali. Malar J (2008) 2.49

A community-based study of the incidence of trimethoprim-sulfamethoxazole-preventable infections in Malawian adults living with HIV. J Acquir Immune Defic Syndr (2005) 2.47

Plasmodium falciparum clearance rates in response to artesunate in Malian children with malaria: effect of acquired immunity. J Infect Dis (2013) 2.47

Risk factors for malaria infection and anemia for pregnant women in the Sahel area of Bandiagara, Mali. Acta Trop (2003) 2.47

Atypical memory B cells are greatly expanded in individuals living in a malaria-endemic area. J Immunol (2009) 2.43

False-negative rapid diagnostic tests for malaria and deletion of the histidine-rich repeat region of the hrp2 gene. Am J Trop Med Hyg (2012) 2.43

Development of a metabolically active, non-replicating sporozoite vaccine to prevent Plasmodium falciparum malaria. Hum Vaccin (2010) 2.36

Clearance of drug-resistant parasites as a model for protective immunity in Plasmodium falciparum malaria. Am J Trop Med Hyg (2003) 2.29

Ethical data release in genome-wide association studies in developing countries. PLoS Med (2009) 2.23

Differential var gene transcription in Plasmodium falciparum isolates from patients with cerebral malaria compared to hyperparasitaemia. Mol Biochem Parasitol (2006) 2.22

Impact of HIV-associated immunosuppression on malaria infection and disease in Malawi. J Infect Dis (2006) 2.22

A randomized trial of doxycycline for Mansonella perstans infection. N Engl J Med (2009) 2.21

Space-time clustering of childhood malaria at the household level: a dynamic cohort in a Mali village. BMC Public Health (2006) 2.20

Impaired cytoadherence of Plasmodium falciparum-infected erythrocytes containing sickle hemoglobin. Proc Natl Acad Sci U S A (2008) 2.19

Towards an RTS,S-based, multi-stage, multi-antigen vaccine against falciparum malaria: progress at the Walter Reed Army Institute of Research. Vaccine (2005) 2.18

Abnormal display of PfEMP-1 on erythrocytes carrying haemoglobin C may protect against malaria. Nature (2005) 2.17

In Tanzania, hemolysis after a single dose of primaquine coadministered with an artemisinin is not restricted to glucose-6-phosphate dehydrogenase-deficient (G6PD A-) individuals. Antimicrob Agents Chemother (2010) 2.15

Valid consent for genomic epidemiology in developing countries. PLoS Med (2007) 2.14

A randomized controlled phase 2 trial of the blood stage AMA1-C1/Alhydrogel malaria vaccine in children in Mali. Vaccine (2009) 2.12

Subcutaneous infection with Dirofilaria immitis nematode in human, France. Emerg Infect Dis (2013) 2.10

Blood group O protects against severe Plasmodium falciparum malaria through the mechanism of reduced rosetting. Proc Natl Acad Sci U S A (2007) 2.07

The Plasmodium falciparum-specific human memory B cell compartment expands gradually with repeated malaria infections. PLoS Pathog (2010) 2.03

Community permission for medical research in developing countries. Clin Infect Dis (2005) 2.01

Artemisinin-resistant malaria: research challenges, opportunities, and public health implications. Am J Trop Med Hyg (2012) 1.97

Efficacy, safety, and selection of molecular markers of drug resistance by two ACTs in Mali. Am J Trop Med Hyg (2008) 1.95

Extreme polymorphism in a vaccine antigen and risk of clinical malaria: implications for vaccine development. Sci Transl Med (2009) 1.95

Safety and immunogenicity of an AMA-1 malaria vaccine in Malian adults: results of a phase 1 randomized controlled trial. PLoS One (2008) 1.90

Impact of preseason treatment on incidence of falciparum malaria and parasite density at a site for testing malaria vaccines in Bandiagara, Mali. Am J Trop Med Hyg (2002) 1.88

No evidence of delayed parasite clearance after oral artesunate treatment of uncomplicated falciparum malaria in Mali. Am J Trop Med Hyg (2012) 1.87

Impact of trimethoprim-sulfamethoxazole prophylaxis on falciparum malaria infection and disease. J Infect Dis (2005) 1.86

Association of Schistosoma haematobium infection with protection against acute Plasmodium falciparum malaria in Malian children. Am J Trop Med Hyg (2005) 1.86

Dynamics of polymorphism in a malaria vaccine antigen at a vaccine-testing site in Mali. PLoS Med (2007) 1.78